245 related articles for article (PubMed ID: 21586362)
21. Purinergic regulation of epithelial transport.
Bucheimer RE; Linden J
J Physiol; 2004 Mar; 555(Pt 2):311-21. PubMed ID: 14694149
[TBL] [Abstract][Full Text] [Related]
22. Extracellular ATP-induced calcium signaling in mIMCD-3 cells requires both P2X and P2Y purinoceptors.
Xia SL; Wang L; Cash MN; Teng X; Schwalbe RA; Wingo CS
Am J Physiol Renal Physiol; 2004 Aug; 287(2):F204-14. PubMed ID: 15068972
[TBL] [Abstract][Full Text] [Related]
23. Pharmacological profiles of cloned mammalian P2Y-receptor subtypes.
von Kügelgen I
Pharmacol Ther; 2006 Jun; 110(3):415-32. PubMed ID: 16257449
[TBL] [Abstract][Full Text] [Related]
24. Stimulation of lipogenesis in rat adipocytes by ATP, a ligand for P2-receptors.
Schödel J; Weise I; Klinger R; Schmidt M
Biochem Biophys Res Commun; 2004 Sep; 321(4):767-73. PubMed ID: 15358093
[TBL] [Abstract][Full Text] [Related]
25. Purinergic receptors in gastrointestinal inflammation.
Kolachala VL; Bajaj R; Chalasani M; Sitaraman SV
Am J Physiol Gastrointest Liver Physiol; 2008 Feb; 294(2):G401-10. PubMed ID: 18063703
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological characterization of P2Y receptor subtypes on isolated tiger salamander Müller cells.
Reifel Saltzberg JM; Garvey KA; Keirstead SA
Glia; 2003 Apr; 42(2):149-59. PubMed ID: 12655599
[TBL] [Abstract][Full Text] [Related]
27. Adenine nucleotides inhibit proliferation of the human lung adenocarcinoma cell line LXF-289 by activation of nuclear factor kappaB1 and mitogen-activated protein kinase pathways.
Schäfer R; Hartig R; Sedehizade F; Welte T; Reiser G
FEBS J; 2006 Aug; 273(16):3756-67. PubMed ID: 16911524
[TBL] [Abstract][Full Text] [Related]
28. Impact of ectonucleotidases in autonomic nervous functions.
Cardoso AM; Schetinger MR; Correia-de-Sá P; Sévigny J
Auton Neurosci; 2015 Sep; 191():25-38. PubMed ID: 26008223
[TBL] [Abstract][Full Text] [Related]
29. P2 receptor signaling in neurons and glial cells of the central nervous system.
Köles L; Leichsenring A; Rubini P; Illes P
Adv Pharmacol; 2011; 61():441-93. PubMed ID: 21586367
[TBL] [Abstract][Full Text] [Related]
30. Control of Gut Inflammation by Modulation of Purinergic Signaling.
Vuerich M; Mukherjee S; Robson SC; Longhi MS
Front Immunol; 2020; 11():1882. PubMed ID: 33072065
[TBL] [Abstract][Full Text] [Related]
31. ATP stimulates glucose transport through activation of P2 purinergic receptors in C(2)C(12) skeletal muscle cells.
Kim MS; Lee J; Ha J; Kim SS; Kong Y; Cho YH; Baik HH; Kang I
Arch Biochem Biophys; 2002 May; 401(2):205-14. PubMed ID: 12054471
[TBL] [Abstract][Full Text] [Related]
32. Diabetes and hypertension: Pivotal involvement of purinergic signaling.
Reichert KP; Castro MFV; Assmann CE; Bottari NB; Miron VV; Cardoso A; Stefanello N; Morsch VMM; Schetinger MRC
Biomed Pharmacother; 2021 May; 137():111273. PubMed ID: 33524787
[TBL] [Abstract][Full Text] [Related]
33. Purinergic Signaling in Controlling Macrophage and T Cell Functions During Atherosclerosis Development.
Ferrari D; la Sala A; Milani D; Celeghini C; Casciano F
Front Immunol; 2020; 11():617804. PubMed ID: 33664731
[TBL] [Abstract][Full Text] [Related]
34. Purinergic contribution to amyotrophic lateral sclerosis.
Volonté C; Apolloni S; Parisi C; Amadio S
Neuropharmacology; 2016 May; 104():180-93. PubMed ID: 26514402
[TBL] [Abstract][Full Text] [Related]
35. Ribose modified nucleosides and nucleotides as ligands for purine receptors.
Jacobson KA; Ravi RG; Nandanan E; Kim HS; Moro S; Kim YC; Lee K; Barak D; Marquez VE; Ji XD
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):333-41. PubMed ID: 11563046
[TBL] [Abstract][Full Text] [Related]
36. ATP- and adenosine-mediated signaling in the central nervous system: adenosine receptor activation by ATP through rapid and localized generation of adenosine by ecto-nucleotidases.
Matsuoka I; Ohkubo S
J Pharmacol Sci; 2004 Feb; 94(2):95-9. PubMed ID: 14978343
[TBL] [Abstract][Full Text] [Related]
37. Purinergic and pyrimidinergic receptors as potential drug targets.
Williams M; Jarvis MF
Biochem Pharmacol; 2000 May; 59(10):1173-85. PubMed ID: 10736418
[TBL] [Abstract][Full Text] [Related]
38. [Nucelotide receptors in cancer cells].
Krzeminski P
Postepy Biochem; 2014; 60(4):490-505. PubMed ID: 25807828
[TBL] [Abstract][Full Text] [Related]
39. Purinergic receptors in microglia: functional modal shifts of microglia mediated by P2 and P1 receptors.
Koizumi S; Ohsawa K; Inoue K; Kohsaka S
Glia; 2013 Jan; 61(1):47-54. PubMed ID: 22674620
[TBL] [Abstract][Full Text] [Related]
40. Purinergic signaling in atherosclerosis.
Ferrari D; Vitiello L; Idzko M; la Sala A
Trends Mol Med; 2015 Mar; 21(3):184-92. PubMed ID: 25637413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
